Predictive Oncology Inc. — Director's Dealing 2021

Mar 30, 2021

SEC Form 4/A — Form 4/A

Issuer: Predictive Oncology Inc. (POAI)
CIK: 0001446159
Period of Report: 2021-02-24

Reporting Person: Schwartz Carl I. (Former CEO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2021-02-24	Common Stock	A	100401	$1.43	Acquired	1711742	Direct

Footnotes

F1: On April 21, 2020, the reporting person exchanged an outstanding promissory note of the issuer for shares of common stock at $1.43 per share pursuant to an exchange agreement. The parties subsequently discovered a calculation error under which an additional $143,574 in interest should have been included in the balance of the exchanged note as of April 21, 2020, and the additional shares reported herein were issued on account of such additional interest.

F2: This form is being amended to correct the transaction code to an "A" to reflect that the transaction between the Issuer and Officer (at the time) is exempt under Rule 16b-3(d).